21-Hydroxypregnenolone
A steroid hormone involved in the biosynthesis of other steroids
21-Hydroxypregnenolone is a steroid hormone that plays a crucial role in the biosynthesis of other important steroid hormones. It is a hydroxylated derivative of pregnenolone, which is a precursor in the synthesis of glucocorticoids, mineralocorticoids, and androgens.
Structure[edit]
21-Hydroxypregnenolone is characterized by the addition of a hydroxyl group at the 21st carbon position of the pregnenolone molecule. This modification is catalyzed by the enzyme 21-hydroxylase, which is essential for the production of corticosteroids in the adrenal cortex.
Biosynthesis[edit]
The biosynthesis of 21-hydroxypregnenolone begins with cholesterol, which is converted into pregnenolone. Pregnenolone is then hydroxylated at the 21st position by 21-hydroxylase to form 21-hydroxypregnenolone. This compound can be further converted into other steroid hormones, such as cortisol and aldosterone, through additional enzymatic reactions.
Function[edit]
21-Hydroxypregnenolone serves as an intermediate in the production of several vital hormones. It is involved in the synthesis of glucocorticoids, which are important for metabolism, immune response, and stress response. It also contributes to the production of mineralocorticoids, which regulate electrolyte and water balance in the body.
Clinical Significance[edit]
Deficiencies in the enzyme 21-hydroxylase can lead to disorders such as congenital adrenal hyperplasia (CAH), which is characterized by impaired production of cortisol and aldosterone. This can result in a range of symptoms, including salt-wasting, hypotension, and virilization.
Related pages[edit]
Gallery[edit]
-
Chemical structure of 21-Hydroxypregnenolone
-
3D model of 17-Hydroxypregnenolone
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian